Literature DB >> 33390938

Quality Markers for Astragali Radix and Its Products Based on Process Analysis.

Yuntao Dai1, Dongbo Wang1, Manjia Zhao1, Lihua Yan1, Chao Zhu2, Pengyue Li1, Xuemei Qin3, Rob Verpoorte4, Shilin Chen1.   

Abstract

Due to the complex nature of traditional medicines, quality control methods need to cover two aspects: compliance of raw materials with quality standards and process control. Astragali radix (AR), the roots of Astragalus mongholicus Bunge, was selected in this study as an example of a widely used traditional medicine in various formulations. Astragaloside IV (AG IV) and calycosin 7-O-β-D-glucoside (CG) are used as the markers for the quality control of AR and its products in the Chinese Pharmacopoeia. However, in the raw materials, malic acid esters of the CG and acetate esters of the astragaloside are easily decomposed into CG and AG IV during storage and processing of AR to make extracts for various preparations. The thermal stability of the isoflavonoids and astragalosides in decoction was studied. The level of CG and astragalosides (AG I/AG II/AG IV) was strongly affected by prolonged heat during processing, while calycosin was stable in the conditions. Also the major astragalosides in AR could fully converted into AG IV which eventually reaches a stable level under certain conditions. With calycosin and AG IV as marker components, practical, reproducible, and precise methods were established and applied to the quality analysis of AR from its raw materials to its intermediates and products. This study demonstrates that a full chemical profiles analysis of the whole manufacturing process (from "raw materials-intermediates/extracts-final product") is important to identify quality markers (Q-markers) and even to establish proper analysis methods for traditional Chinese medicine products.
Copyright © 2020 Dai, Wang, Zhao, Yan, Zhu, Li, Qin, Verpoorte and Chen.

Entities:  

Keywords:  astragali radix; fingerprint analysis; process analysis; quality control; quality markers

Year:  2020        PMID: 33390938      PMCID: PMC7775524          DOI: 10.3389/fphar.2020.554777

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  3 in total

Review 1.  Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease.

Authors:  Qianyu Dong; Zhen Li; Qian Zhang; Yueyu Hu; Huazheng Liang; Lize Xiong
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

2.  Evaluation of processing mechanism in Astragali Radix by low-field nuclear magnetic resonance and magnetic resonance imaging.

Authors:  Jie Peng; Lifang Ye; Mengmei Wu; Menghua Wu; Zhiguo Ma; Hui Cao; Ying Zhang
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

3.  Effects of Physical Properties and Processing Methods on Astragaloside IV and Flavonoids Content in Astragali radix.

Authors:  Mei-Yin Chien; Chih-Min Yang; Chao-Hsiang Chen
Journal:  Molecules       Date:  2022-01-17       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.